IRulya Therapeutics Inc.
IRLA· Nasdaq
IRulya Therapeutics Inc.
- Last sale
- Oct 15, 2026 · +10.42%
- Market cap
- $33.91M
- 1.02M shares
- Filings
- 453
Price
Oct 15, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $35,382,000 | reported | |
| FY 2024 | 2024-12-31 | $18,590,000 | reported | |
| FY 2023 | 2023-12-31 | $9,447,000 | reported | |
| FY 2022 | 2022-12-31 | $25,178,000 | reported | |
| FY 2021 | 2021-12-31 | $60,795,000 | reported | |
| FY 2020 | 2020-12-31 | $61,307,000 | reported | |
| FY 2019 | 2019-12-31 | $30,214,000 | reported | |
| FY 2018 | 2018-12-31 | $10,085,000 | reported |
IRulya Therapeutics Inc. · CIK 1662774 · Engraved from SEC EDGAR
